We are live on ! Find out more
Glazer Capital

Glazer Capital Portfolio holdings

AUM $4.07B Turnover 45.75%
1-Year Est. Return 78.71%
 

Glazer Capital runs event-driven strategies that aim to make money when an announced merger, acquisition or tender offer closes successfully. Its four main strategies are merger arbitrage, event-driven fixed income, convertible arbitrage and arbitrage on SPACs, and it invests across companies' capital structures, in both stocks and debt. Founder and chief executive Paul Glazer spent ten years on the sell side at Houlihan Lokey, Jefferies, Bear Stearns and Oscar Gruss, where he focused on merger arbitrage. He and Mark Ort, head of strategic initiatives, are the firm's principal owners. In 2010 it began offering leveraged versions of its strategies at investors' request, and in 2024 it opened an office in the UK.

This Fund
S&P 500
This Quarter Est. Return
+12.21%
1 Year Est. Return
+78.71%
3 Year Est. Return
+323.31%
5 Year Est. Return
+574.14%
10 Year Est. Return
+3,824.29%
AUM
$4.07B
AUM Growth
-$648M
Cap. Flow
-$794M
Cap. Flow %
-19.53%
Top 10 Hldgs %
38.61%
Holding
682
New
190
Increased
111
Reduced
139
Closed
122
Avg Time Held Equity + Options
0.4 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0.4 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Buys

Rank Stock Value
1
JHG icon
Janus Henderson
JHG
+$287M
2
BLD icon
TopBuild
BLD
+$203M
3
NUVL icon
Nuvalent
NUVL
+$190M
4
APGE icon
Apogee Therapeutics
APGE
+$148M
5
SEM icon
Select Medical
SEM
+$110M

Top Sells

Rank Stock Value
1
AL icon
Air Lease Corp
AL
+$351M
2
HOLX icon
Hologic
HOLX
+$269M
3
SEE icon
Sealed Air
SEE
+$214M
4
CWAN icon
Clearwater Analytics
CWAN
+$185M
5
FOLD icon
Amicus Therapeutics
FOLD
+$184M

Sector Composition

Rank Sector Weight
1 Financials 47.68%
2 Healthcare 23.76%
3 Industrials 8.22%
4 Miscellaneous 5.88%
5 Communication Services 4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JHG icon
1
DELISTED
Janus Henderson
JHG
$324M 7.97%
6,234,419
+5,552,165
+814% +$287M
2025 Q4
2 quarters
NUVL icon
2
DELISTED
Nuvalent
NUVL
$219M 5.38%
+1,769,665
New +$190M
2026 Q2
0 quarters
APGE icon
3
DELISTED
Apogee Therapeutics
APGE
$218M 5.36%
+1,641,042
New +$148M
2026 Q2
0 quarters
BLD icon
4
DELISTED
TopBuild
BLD
$210M 5.16%
+492,249
New +$203M
2026 Q2
0 quarters
SEM icon
5
DELISTED
Select Medical
SEM
$177M 4.36%
10,744,069
+6,664,289
+163% +$110M
2026 Q1
1 quarter
CPRX icon
6
DELISTED
Catalyst Pharmaceutical
CPRX
$113M 2.79%
+3,602,865
New +$106M
2026 Q2
0 quarters
HBM icon
7
Hudbay
HBM
$9.5B
$83.8M 2.06%
+3,550,164
New +$89.8M
2026 Q2
0 quarters
DBRG icon
8
DELISTED
DigitalBridge
DBRG
$77.7M 1.91%
4,927,041
-4,374,584
-47% -$68.4M
2025 Q4
2 quarters
GTLS icon
9
DELISTED
Chart Industries
GTLS
$74.8M 1.84%
357,757
+206,186
+136% +$42.8M
2025 Q4
2 quarters
CZR icon
10
Caesars Entertainment
CZR
$5.98B
$72.8M 1.79%
+2,412,764
New +$68M
2026 Q2
0 quarters
ESPR icon
11
DELISTED
Esperion Therapeutics
ESPR
$70.8M 1.74%
+22,416,339
New +$62.7M
2026 Q2
0 quarters
WBS icon
12
DELISTED
Webster Financial
WBS
$69.2M 1.7%
905,957
+784,585
+646% +$57.1M
2026 Q1
1 quarter
SILA
13
DELISTED
Sila Realty Trust
SILA
$68.1M 1.68%
+2,241,969
New +$65.6M
2026 Q2
0 quarters
PEN icon
14
Penumbra
PEN
$12.6B
$49.9M 1.23%
158,127
+63,308
+67% +$20.5M
2026 Q1
1 quarter
GBTG icon
15
DELISTED
American Express Global Business Travel
GBTG
$48M 1.18%
+5,115,013
New +$41.5M
2026 Q2
0 quarters
OGN icon
16
Organon & Co
OGN
$3.65B
$37.2M 0.91%
+2,745,000
New +$32.8M
2026 Q2
0 quarters
ACA icon
17
DELISTED
Arcosa
ACA
$36.3M 0.89%
+250,095
New +$31.1M
2026 Q2
0 quarters
WSR
18
DELISTED
Whitestone REIT
WSR
$35.7M 0.88%
+1,883,574
New +$35.4M
2026 Q2
0 quarters
TBRG icon
19
DELISTED
TruBridge
TBRG
$31.6M 0.78%
+1,204,554
New +$29.5M
2026 Q2
0 quarters
LBRDK icon
20
DELISTED
Liberty Broadband Class C
LBRDK
$29.8M 0.73%
895,704
+634,716
+243% +$24.7M
2025 Q3
3 quarters
CCO icon
21
DELISTED
Clear Channel Outdoor Holdings
CCO
$29.8M 0.73%
12,298,891
+11,298,891
+1,130% +$27.1M
2026 Q1
1 quarter
EEX icon
22
DELISTED
Emerald Holding
EEX
$29.6M 0.73%
+5,868,381
New +$28.5M
2026 Q2
0 quarters
ROKU icon
23
DELISTED
Roku
ROKU
$27.7M 0.68%
+200,666
New +$24.5M
2026 Q2
0 quarters
AES icon
24
AES
AES
$10.6B
$24.8M 0.61%
1,689,649
+289,649
+21% +$4.21M
2026 Q1
1 quarter
DMII icon
25
Drugs Made In America Acquisition II Corp
DMII
$652M
$23.6M 0.58%
2,343,278
-6,483
-0.3% -$65.1K
2025 Q4
2 quarters

Similar funds

Glazer Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Glazer Capital held 682 positions worth $4.07B, down 14% from $4.71B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Glazer Capital withdrew a net $794M in Q2 2026, closing 122 positions and reducing 139 holdings. Its most notable exit was Air Lease Corp, an estimated $351M position sold in full.

By sector, the portfolio is most concentrated in Financials at 48% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Glazer Capital opened a new position in TopBuild worth $210M.

  • Glazer Capital's largest Q2 2026 buy was TopBuild: 492,249 shares worth $210M.
  • Glazer Capital added most to Janus Henderson in Q2 2026, an estimated $287M increase.
  • Glazer Capital's biggest Q2 2026 reduction was Brighthouse Financial, cutting an estimated $133M.
  • Glazer Capital fully exited Air Lease Corp in Q2 2026, selling an estimated $351M.
  • Glazer Capital's ten largest holdings make up 39% of its $4.07B portfolio in Q2 2026.
  • Glazer Capital opened 190 new positions and closed 122 in Q2 2026.
  • Glazer Capital's portfolio value fell 14% quarter-over-quarter to $4.07B.

Based on Glazer Capital's 13F filing for Q2 2026, filed 17 Aug 2026.